vs
Side-by-side financial comparison of SANFILIPPO JOHN B & SON INC (JBSS) and Natural Grocers by Vitamin Cottage, Inc. (NGVC). Click either name above to swap in a different company.
Natural Grocers by Vitamin Cottage, Inc. is the larger business by last-quarter revenue ($335.6M vs $314.8M, roughly 1.1× SANFILIPPO JOHN B & SON INC). SANFILIPPO JOHN B & SON INC runs the higher net margin — 5.7% vs 3.4%, a 2.3% gap on every dollar of revenue. On growth, SANFILIPPO JOHN B & SON INC posted the faster year-over-year revenue change (4.6% vs 1.6%). SANFILIPPO JOHN B & SON INC produced more free cash flow last quarter ($40.0M vs $11.6M). Over the past eight quarters, SANFILIPPO JOHN B & SON INC's revenue compounded faster (7.6% CAGR vs 4.4%).
John B. Sanfilippo & Son Inc. (JBSS) is a leading US processor, marketer and distributor of high-quality tree nuts, peanuts, dried fruits, and value-added snack products. It serves retail, foodservice, and industrial ingredient customers primarily across North America, offering both branded and private label product lines.
Natural Grocers by Vitamin Cottage, Inc. is a U.S.-based specialty retail chain that offers certified organic groceries, dietary supplements, natural personal care items, and eco-friendly household products. It serves health-conscious consumers across multiple U.S. states, following strict quality standards that exclude artificial preservatives, colors, flavors and harmful additives.
JBSS vs NGVC — Head-to-Head
Income Statement — Q2 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $314.8M | $335.6M |
| Net Profit | $18.0M | $11.3M |
| Gross Margin | 18.8% | 29.5% |
| Operating Margin | 8.3% | 4.4% |
| Net Margin | 5.7% | 3.4% |
| Revenue YoY | 4.6% | 1.6% |
| Net Profit YoY | 32.1% | 14.0% |
| EPS (diluted) | $1.53 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $314.8M | $335.6M | ||
| Q3 25 | $298.7M | $336.1M | ||
| Q2 25 | $269.1M | $328.7M | ||
| Q1 25 | $260.9M | $335.8M | ||
| Q4 24 | $301.1M | $330.2M | ||
| Q3 24 | $276.2M | $322.7M | ||
| Q2 24 | $269.6M | $309.1M | ||
| Q1 24 | $271.9M | $308.1M |
| Q4 25 | $18.0M | $11.3M | ||
| Q3 25 | $18.7M | $11.8M | ||
| Q2 25 | $13.5M | $11.6M | ||
| Q1 25 | $20.2M | $13.1M | ||
| Q4 24 | $13.6M | $9.9M | ||
| Q3 24 | $11.7M | $9.0M | ||
| Q2 24 | $10.0M | $9.2M | ||
| Q1 24 | $13.5M | $8.0M |
| Q4 25 | 18.8% | 29.5% | ||
| Q3 25 | 18.1% | 29.5% | ||
| Q2 25 | 18.1% | 29.9% | ||
| Q1 25 | 21.4% | 30.3% | ||
| Q4 24 | 17.4% | 29.9% | ||
| Q3 24 | 16.9% | 29.6% | ||
| Q2 24 | 18.5% | 29.2% | ||
| Q1 24 | 18.1% | 29.3% |
| Q4 25 | 8.3% | 4.4% | ||
| Q3 25 | 9.0% | 4.6% | ||
| Q2 25 | 7.5% | 4.7% | ||
| Q1 25 | 10.8% | 5.2% | ||
| Q4 24 | 6.4% | 4.0% | ||
| Q3 24 | 6.2% | 3.7% | ||
| Q2 24 | 5.4% | 4.2% | ||
| Q1 24 | 6.7% | 3.7% |
| Q4 25 | 5.7% | 3.4% | ||
| Q3 25 | 6.3% | 3.5% | ||
| Q2 25 | 5.0% | 3.5% | ||
| Q1 25 | 7.7% | 3.9% | ||
| Q4 24 | 4.5% | 3.0% | ||
| Q3 24 | 4.2% | 2.8% | ||
| Q2 24 | 3.7% | 3.0% | ||
| Q1 24 | 5.0% | 2.6% |
| Q4 25 | $1.53 | $0.49 | ||
| Q3 25 | $1.59 | $0.51 | ||
| Q2 25 | $1.15 | $0.50 | ||
| Q1 25 | $1.72 | $0.56 | ||
| Q4 24 | $1.16 | $0.43 | ||
| Q3 24 | $1.00 | $0.38 | ||
| Q2 24 | $0.85 | $0.40 | ||
| Q1 24 | $1.15 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.4M | $23.2M |
| Total DebtLower is stronger | $28.8M | — |
| Stockholders' EquityBook value | $370.1M | $220.0M |
| Total Assets | $617.7M | $668.6M |
| Debt / EquityLower = less leverage | 0.08× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.4M | $23.2M | ||
| Q3 25 | $714.0K | $17.1M | ||
| Q2 25 | $585.0K | $13.2M | ||
| Q1 25 | $1.3M | $21.2M | ||
| Q4 24 | $336.0K | $6.3M | ||
| Q3 24 | $442.0K | $8.9M | ||
| Q2 24 | $484.0K | $13.9M | ||
| Q1 24 | $377.0K | $11.0M |
| Q4 25 | $28.8M | — | ||
| Q3 25 | $29.8M | — | ||
| Q2 25 | $14.6M | — | ||
| Q1 25 | $5.8M | — | ||
| Q4 24 | $6.0M | — | ||
| Q3 24 | $6.2M | — | ||
| Q2 24 | $6.4M | — | ||
| Q1 24 | $6.6M | — |
| Q4 25 | $370.1M | $220.0M | ||
| Q3 25 | $362.8M | $212.4M | ||
| Q2 25 | $360.7M | $202.5M | ||
| Q1 25 | $346.6M | $193.0M | ||
| Q4 24 | $325.6M | $181.9M | ||
| Q3 24 | $310.8M | $174.3M | ||
| Q2 24 | $322.6M | $167.8M | ||
| Q1 24 | $321.8M | $160.0M |
| Q4 25 | $617.7M | $668.6M | ||
| Q3 25 | $598.7M | $670.5M | ||
| Q2 25 | $597.6M | $659.0M | ||
| Q1 25 | $590.0M | $664.6M | ||
| Q4 24 | $545.3M | $648.9M | ||
| Q3 24 | $519.4M | $655.5M | ||
| Q2 24 | $515.6M | $654.4M | ||
| Q1 24 | $491.9M | $656.6M |
| Q4 25 | 0.08× | — | ||
| Q3 25 | 0.08× | — | ||
| Q2 25 | 0.04× | — | ||
| Q1 25 | 0.02× | — | ||
| Q4 24 | 0.02× | — | ||
| Q3 24 | 0.02× | — | ||
| Q2 24 | 0.02× | — | ||
| Q1 24 | 0.02× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $62.5M | $21.1M |
| Free Cash FlowOCF − Capex | $40.0M | $11.6M |
| FCF MarginFCF / Revenue | 12.7% | 3.4% |
| Capex IntensityCapex / Revenue | 7.1% | 2.9% |
| Cash ConversionOCF / Net Profit | 3.48× | 1.86× |
| TTM Free Cash FlowTrailing 4 quarters | $32.8M | $42.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $62.5M | $21.1M | ||
| Q3 25 | $32.1M | $15.6M | ||
| Q2 25 | $36.5M | $2.9M | ||
| Q1 25 | $-25.9M | $34.1M | ||
| Q4 24 | $11.0M | $2.7M | ||
| Q3 24 | $8.9M | $24.5M | ||
| Q2 24 | $35.2M | $12.4M | ||
| Q1 24 | $5.3M | $20.2M |
| Q4 25 | $40.0M | $11.6M | ||
| Q3 25 | $7.3M | $7.5M | ||
| Q2 25 | $23.0M | $-4.2M | ||
| Q1 25 | $-37.6M | $27.6M | ||
| Q4 24 | $-2.7M | $-6.9M | ||
| Q3 24 | $-3.0M | $18.0M | ||
| Q2 24 | $24.4M | $3.6M | ||
| Q1 24 | $-1.3M | $9.8M |
| Q4 25 | 12.7% | 3.4% | ||
| Q3 25 | 2.4% | 2.2% | ||
| Q2 25 | 8.6% | -1.3% | ||
| Q1 25 | -14.4% | 8.2% | ||
| Q4 24 | -0.9% | -2.1% | ||
| Q3 24 | -1.1% | 5.6% | ||
| Q2 24 | 9.0% | 1.2% | ||
| Q1 24 | -0.5% | 3.2% |
| Q4 25 | 7.1% | 2.9% | ||
| Q3 25 | 8.3% | 2.4% | ||
| Q2 25 | 5.0% | 2.2% | ||
| Q1 25 | 4.5% | 1.9% | ||
| Q4 24 | 4.5% | 2.9% | ||
| Q3 24 | 4.3% | 2.0% | ||
| Q2 24 | 4.0% | 2.9% | ||
| Q1 24 | 2.4% | 3.4% |
| Q4 25 | 3.48× | 1.86× | ||
| Q3 25 | 1.72× | 1.32× | ||
| Q2 25 | 2.70× | 0.25× | ||
| Q1 25 | -1.29× | 2.60× | ||
| Q4 24 | 0.81× | 0.27× | ||
| Q3 24 | 0.77× | 2.72× | ||
| Q2 24 | 3.52× | 1.35× | ||
| Q1 24 | 0.39× | 2.54× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
JBSS
| Sales Channel Directly To Consumer | $263.2M | 84% |
| Sales Channel Commercial Ingredients | $28.0M | 9% |
| Sales Channel Contract Packaging | $23.6M | 8% |
NGVC
| Grocery | $243.8M | 73% |
| Dietary Supplements | $60.7M | 18% |
| Manufactured Product Other | $31.0M | 9% |
